Intensive versus intermediate glucose control in surgical intensive care unit patients

Diabetes Care

Volumn 37, Issue 6, 2014, Pages 1516-1524

  Okabayashi, Takehiro ^a,b   Shima, Yasuo ^b   Sumiyoshi, Tatsuaki ^b   Kozuki, Akihito ^b   Tokumaru, Teppei ^b   Iiyama, Tasuo ^c   Sugimoto, Takeki ^a   Kobayashi, Michiya ^a   Yokoyama, Masataka ^a   Hanazaki, Kazuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Kochi Health Sciences Center   (Japan)

^c KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

AGED; ARTICLE; BILE LEAKAGE; BILIARY TRACT SURGERY; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; OPERATION DURATION; OUTCOME ASSESSMENT; PANCREAS FISTULA; PANCREAS SURGERY; PARENTERAL NUTRITION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL INFECTION; BILIARY TRACT DISEASES; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; LIVER DISEASES; METABOLISM; PANCREATIC DISEASES; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURGICAL WOUND INFECTION;

AGED; BILIARY TRACT DISEASES; BLOOD GLUCOSE; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; LIVER DISEASES; MALE; PANCREATIC DISEASES; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 84901409666     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1771     Document Type: Article

References (30)

1. Finfer S, Chittock DR, Su SY, et al.; NICESUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297
2. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367
3. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
4. Duckworth W, Abraira C, Moritz T, et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
5. Brunkhorst FM, Engel C, Bloos F, et al.; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139
6. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009;35: 1738-1748
7. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300:933-944
8. Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res Rev 2007;23:184-192
9. Griesdale DE, de Souza RJ, van DamRM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009;180:821-827
10. van den Berghe G. Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l. Diabetologia 2008;51:911-915
11. Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci U S A 1918;4:370-373
12. Yamashita K, Okabayashi T, Yokoyama T, et al. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 2008;106:160-163
13. Yamashita K, Okabayashi T, Yokoyama T, et al. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand 2009;53:66-71
14. Hanazaki K, Nos ́e Y, Brunicardi FC. Artificial endocrine pancreas. J Am Coll Surg 2001;193: 310-322
15. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461
16. Van den Berghe G, Schetz M, Vlasselaers D, et al. Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 2009;94:3163-3170
17. Alfonso A, Koops MK, Mong DP, Vigersky RA. Glycemic control with regular versus lispro insulin sliding scales in hospitalized Type 2 diabetics. J Diabetes Complications 2006;20:153-157
18. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-608
19. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-360; discussion 360-362
20. Greif R, Akça O, Horn EP, Kurz A, Sessler DI; Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000; 342:161-167
21. Okabayashi T, Nishimori I, Maeda H, Yamashita K, Yatabe T, Hanazaki K. Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial.diabetes Care 2009;32:1425-1427
22. Okabayashi T, Nishimori I, Yamashita K, et al. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial. Arch Surg 2009; 144:933-937
23. Bell ML, Kenward MG, Fairclough DL, Horton NJ. Differential dropout and bias in randomised controlled trials: when it matters and when it may not. BMJ 2013;346:e8668
24. BoltzMM, Hollenbeak CS, Julian KG, Ortenzi G, Dillon PW. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery 2011;150:934-942
25. de Blacam C, Ogunleye AA, Momoh AO, et al. High body mass index and smoking predict morbidity in breast cancer surgery: a multivariate analysis of 26,988 patients from the national surgical quality improvement program database. Ann Surg 2012;255:551-555
26. Wukich DK, McMillen RL, Lowery NJ, Frykberg RG. Surgical site infections after foot and ankle surgery: a comparison of patients with and without diabetes. Diabetes Care 2011;34:2211-2213
27. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. Clinical guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients, 2009. JPEN J Parenter Enteral Nutr 2009;33:255-259
28. Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009;28:387-400
29. Kavanagh BP, McCowen KC. Clinical practice. Glycemic control in the ICU. N Engl J Med 2010;363:2540-2546
30. Bowman RL, Blume P, Vurek GG. Capillarytube scanner for mechanized microbiology. A photoelectric scanner measures growth in agar-filled capillaries and gives a new approach to microbiology. Science 1967;158:78-83